Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Community-Acquired Pneumonia

• Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia
• Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults
• Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults
• Coenzyme Q10 in Pediatric Community-Acquired Pneumonia
• Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma
• Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
• Corticosteroids for PJP in Non-HIV Immunocompromised Adults
• Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults
• Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)
• Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea
• Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)
• Local Antibiotic Delivery for Community Acquired Pneumonia
• Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)
• Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia
• Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia
• OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis
• Efficacy and Safety of SR1375 in Adult Patients With CAP
• Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone
• Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
• Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.
• A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
• The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)
• Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
• Stopping Pneumonia Antibiotherapy Regimen Early
• Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia
• Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
• CX-4945 in Viral Community Acquired Pneumonia
• Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.